Growth and bone health in paediatric patients with Crohn's disease receiving subcutaneous tumor necrosis factor antibody

Table 2 Anthropometry, inflammatory marker and puberty status at start of adalimumab

Anthropometric details1
Weight SDS	-0.5 ± 1.2
Height SDS	-0.7 ± 1.1
BMI SDS	-0.5 ± 1.3
Inflammation
PCDAI	52 ± 16
CRP (mg/dL)	1.6 ± 1.6
ESR (mm/h)	49 ± 20.1
Leucocytes (/nL)	10.3 ± 4.4
Albumin (g/dL)	3.7 ± 0.6
Tanner staging2
Tanner 1	4 (22)
Tanner 2	3 (17)
Tanner 3	2 (11)
Tanner 4	6 (33)
Tanner 5	3 (17)

¹Results are presented as mean ± SD;

²Results are presented as number (% of total). BMI: Body mass index; PCDAI: Paediatric Crohn’s disease activity index; CRP: C-reactive protein; ESR: Erythrocyte sedimentation rate; SDS: Standard deviation score.